Literature DB >> 2492217

The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.

I Murai1, S Reichlin, N Ben-Jonathan.   

Abstract

UNLABELLED: The proestrous surge of PRL could result from a decrease in dopamine, an increase in PRL-releasing factor (PRF) or both. The objectives were to determine whether PRF from the posterior pituitary regulates the proestrous PRL surge, and to examine if there are interactions between PRF and vasoactive intestinal peptide (VIP). Posterior pituitary lobectomy (LOBEX) and passive immunization against VIP were employed. Adult cycling rats were subjected at 0900 h on proestrus to LOBEX or sham surgery (SHAM) under short term anesthesia, and were injected iv at 1330 h with 0.75 ml anti-VIP serum or normal rabbit serum. Jugular blood was collected hourly from 1400-2300 h and analyzed for PRL and LH by RIA. Oviductal ova were examined on estrus. The rise in plasma PRL in normal rabbit serum-treated SHAM rats was biphasic, with an early peak between 1500-1700 h and a lower plateau between 1900-2100 h. This rise was similar in profile and magnitude to that seen in intact rats. In contrast, LOBEX significantly attenuated the early peak, but did not alter the plateau. Passive immunization against VIP of either SHAM or LOBEX rats mimicked the effect of LOBEX alone on PRL release. Neither surgery nor anti-VIP serum affected the profile of the LH surge which was sharp and symmetrical, and all rats ovulated with 15-16 ova per rat. To determine whether VIP is the posterior pituitary PRF, selected tissues removed on proestrus or diestrus-1 were analyzed for VIP by RIA. VIP was undetectable (less than 20 pg/organ) in the posterior pituitary on either day examined. The contents of VIP in the anterior pituitary, medial basal hypothalamus, and paraventricular nuclei were unchanged between diestrus-1 and proestrus.
CONCLUSIONS: The proestrous surge of PRL consists of two components: an early peak and a late plateau. The peak phase appears to be dependent on PRF input from the posterior pituitary. This input might be regulated by VIP, and interactions between the two could occur at the level of the hypothalamus, anterior pituitary, or both. The plateau phase of the PRL surge is independent of the posterior pituitary and VIP, and might involve hypothalamic dopamine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492217     DOI: 10.1210/endo-124-2-1050

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Vasoactive intestinal peptide (VIP) mediates the effect of estrogens on the dopaminergic tone in the hypothalamic-pituitary axis of ovariectomized (OVX) rats.

Authors:  M Lasaga; A Seilicovich; D Pisera; M C Díaz; M F Befumo; B H Duvilanski
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

2.  Pituitary portal plasma levels of oxytocin during the estrous cycle, lactation, and hyperprolactinemia.

Authors:  D K Sarkar; S A Frautschy; N Mitsugi
Journal:  Ann N Y Acad Sci       Date:  1992-06-12       Impact factor: 5.691

3.  Effect of posterior pituitary lobectomy on in vivo and in vitro secretion of prolactin in lactating rats.

Authors:  F Mena; D Aguayo; M Vigueras; A Quintanar-Stephano; G Perera; T Morales
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

4.  Progesterone decreases tyrosine hydroxylase phosphorylation state and increases protein phosphatase 2A activity in the stalk-median eminence on proestrous afternoon.

Authors:  Bin Liu; Lydia A Arbogast
Journal:  J Endocrinol       Date:  2009-11-27       Impact factor: 4.286

5.  Vasoactive intestinal polypeptide modulates the estradiol-induced prolactin surge by entraining oxytocin neuronal activity.

Authors:  Jessica E Kennett; Maristela O Poletini; Marc E Freeman
Journal:  Brain Res       Date:  2008-01-03       Impact factor: 3.252

Review 6.  VIP: molecular biology and neurobiological function.

Authors:  I Gozes; D E Brenneman
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

7.  Gender-biased activity of the novel prolactin releasing peptides: comparison with thyrotropin releasing hormone reveals only pharmacologic effects.

Authors:  W K Samson; Z T Resch; T C Murphy; J K Chang
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

Review 8.  60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.

Authors:  David R Grattan
Journal:  J Endocrinol       Date:  2015-06-22       Impact factor: 4.286

Review 9.  Neuroendocrine mechanisms underlying estrogen positive feedback and the LH surge.

Authors:  Alexander S Kauffman
Journal:  Front Neurosci       Date:  2022-07-27       Impact factor: 5.152

10.  Elevated prolactin secretion during proestrus in mice: Absence of a defined surge.

Authors:  Hollian R Phillipps; Zin Khant Aung; David R Grattan
Journal:  J Neuroendocrinol       Date:  2022-05-01       Impact factor: 3.870

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.